[Use of eptifibatide in patients with acute stent thrombosis, requiring urgent surgical revascularisation - report of 2 cases].
Number of patients requiring intensive antiaggregation therapy in diseases of circulatory system is increasing. Simultaneously many patients are referred to CABG. In the article, based on two case reports, we discuss optimal time frame for performing cardiac surgery, methods to analyze platelet inhibition, and we describe technique of bridging by eptifibatide.
Wilczyński
Mirosław
M
Oddział Kardiochirurgii, Slaski Uniwersytet Medyczny, Katowice.
Bochenek
Tomasz
T
Góral
Joanna
J
Knast
Krzysztof
K
Abu Samra
Rafik
R
Wita
Krystian
K
Bochenek
Andrzej
A
D054058:Acute Coronary Syndrome / Q000628:therapy; D001026:Coronary Artery Bypass; D003328:Coronary Thrombosis / Q000188:drug therapy* / Q000209:etiology / Q000601:surgery*; D000077542:Eptifibatide; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000628:therapy; D009204:Myocardial Revascularization; D010455:Peptides / Q000008:administration & dosage*; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage*; D015607:Stents / Q000009:adverse effects*
D010455:Peptides; D010975:Platelet Aggregation Inhibitors; D000077542:Eptifibatide